|
  What is the Truth About the Cost and Utilization
of Medical Technology in Europe vs. the U.S.?
The U.S. spends 15% of its GDP on healthcare for its citizens -- far more than other major industrialized nations of the world. Yet, its overall health outcomes are arguably not correspondingly better.
It is generally believed that much of this additional expenditure in the U.S. comes from a greater use of new medical technologies -- in this case medical equipment and medical devices. There are more MRI machines in Orange County California, for example, than there are in the entire nation of Canada.
At the same time, medical machines and devices have been shown to save money and significantly improve healthcare outcomes. How can we best balance the purchase and use of new medical technologies with optimal outcomes? The Global Medical Forum Foundation's second U.S. Summit addressed this challenge and the following questions
What lessons can American policymakers, providers, and payers learn from the European experience with healthcare machines and devices?
Have the European industrialized nations learned to be better purchasers and users of these new medical technologies?
Have the government run universal systems of care employed by Europeans created incentives for them to be more effective in the purchase and use of these machines?
Are Europeans paying a price in the quality of their healthcare for what appear to be greater European cost efficiencies?
Have Europeans employed such tools as information systems to support the management of these medical technologies or are the apparent savings coming exclusively from payment and capital policies?
The Summit blended selected experts in the European system who have had direct experience in managing the cost and quality of new medical technologies as a policymaker or a provider of healthcare. The one-day program blended the experience of these experts with Americans of parallel experience in a format that used a panel discussion method.
Summit Speakers & Topics: December 3, 2004
9:00 am to 9:40 am: Welcome & Introduction
Prof. Raphael H. Levey, MD; Chairman, Global Medical Forum Foundation
Mr. Robert Laszewski; Chairman North America, Global Medical Forum Foundation
9:40 am to 9:55 am: Keynote
How We in Europe Manage and Capitalize Technology Costs: A German Payer's View
Ms. Anne Haas, Senior Officer for Health Policy, AOK Bundesverband (German national insurer)
9:55 am to 10:40 am: Panel Discussion
Moderator
Mr. Larry Leisure, Senior Vice-President, Kaiser Permanente
Panelists
Dr. Patrick Ryce, Senior Vice President and Medical Director, Blue Cross
Blue Shield of Alabama
Dr. Wendy Everett, ScD, President, New England Healthcare Institute
Dr. Wendy Everett, ScD, President, New England Healthcare Institute
Ms. Jill Berger, Vice President Health and Welfare Plan Management and
Design, Marriott International
10:40 am to 11:00 am: Coffee Break
11:00 am to 11:15 am: Keynote
Technology Usage in Europe vs. North America: The View of a Global
Corporation Operating in Both Markets
Dr. Jenifer Ehreth, Reimbursement Director, Medtronic Europe SA
11:15 am to 12:00 pm: Panel Discussion
Moderator
Dr. Catharina Maulbecker, Chair Europe, Global Medical Forum Foundation
Panelists
Mr. Martin "Chip" Doordan, President, Anne Arundel Health System
Dr. Murray Ross, Ph.D., Director, Health Policy Analysis and Research,
Kaiser Permanente Institute for Health Policy
Mr. Stephen Hull, Vice President Global Strategy & Analysis, Advanced
Medical Technology Association (AdvaMed)
12:00 pm to 1:30 pm: Lunch in The John Hay Room, Hay Adams Hotel
1:30 pm to 1:45 pm: Keynote
How the European Provider Adapts to Available Technology: A
European Provider's View
Prof. Jörg Debatin, MD, Director, Universitätsklinik Hamburg Eppendorf
(major university hospital radiology department)
1:45 pm to 2:30 pm: Panel Discussion
Moderator
Ms. Jane Sarasohn-Kahn, Management Consultant and Health Economist,
Representative of the Institute for the Future
Panelists
Mr. Martin "Chip" Doordan, President, Anne Arundel Health System
Dr. Patrick Ryce, Senior Vice President and Medical Director, Blue Cross
Blue Shield of Alabama
2:30 pm to 2:45 pm: Coffee Break
2:45 pm to 3:00 pm: Keynote
How We in Europe Manage and Capitalize Technology Costs: A British
Policymaker's View
Mr. Andrew Dillon, Chief Executive, National Institute for Clinical
Excellence (oversight of technology for UK National Health System)
3:00 pm to 3:45 pm: Panel Discussion
Moderator
Dr. Paul Ginsburg, Ph.D., President, the Center for Studying Health System
Change
Panelists
Dr. Sean Tunis, MD, MSc., Chief Medical Officer, and Director, Office of
Clinical Standards and Quality, Center for Medicare and Medicaid
Services, US Department of Health and Human Services
Dr. Murray Ross, Ph.D., Director, Health Policy Analysis and Research,
Kaiser Permanente Institute for Health Policy
Ms. Jill Berger, Vice President, Health and Welfare Plan Management and
Design, Marriott International
Mr. Thomas Grissom, Vice President Government Affairs, Boston Scientific Corporation
3:45 pm to 4:15 pm: Audience Discussion
What Can We Conclude?
Moderator: Mr. Robert Laszewski, Global Medical Forum Foundation
|
